Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases
Gabriele Zoppoli(Ospedale Policlinico San Martino), Alberto Ballestrero(Ospedale Policlinico San Martino)
Cited by 28
Related Papers
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
|The Lancet Oncology|2021|355
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair
|Cancer Research|2017|108